Works matching IS 2044-5385 AND VI 13 AND IP 1 AND DT 2023

Results: 252
    1
    2
    3
    4

    Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00967-8
    By:
    • Gagnon, Marie-France;
    • Penheiter, Alan R.;
    • Harris, Faye;
    • Sadeghian, Dorsay;
    • Johnson, Sarah H.;
    • Karagouga, Giannoula;
    • McCune, Alexa;
    • Zepeda-Mendoza, Cinthya;
    • Greipp, Patricia T.;
    • Xu, Xinjie;
    • Ketterling, Rhett P.;
    • McPhail, Ellen D.;
    • King, Rebecca L.;
    • Peterson, Jess F.;
    • Vasmatzis, George;
    • Baughn, Linda B.
    Publication type:
    Article
    5
    6
    7

    The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00960-1
    By:
    • Barbui, Tiziano;
    • Carobbio, Alessandra;
    • Thiele, Juergen;
    • Gangat, Naseema;
    • Rumi, Elisa;
    • Rambaldi, Alessandro;
    • Vannucchi, Alessandro M.;
    • Tefferi, Ayalew;
    • Jeryczynski, Georg;
    • Müllauer, Leonhard;
    • Vaidya, Rakhee;
    • Sulai, Nanna H.;
    • Pardanani, Animesh;
    • Larson, Dirk R.;
    • Cazzola, Mario;
    • Casetti, Ilaria;
    • Finazzi, Guido;
    • Pieri, Lisa;
    • Gisslinger, Heinz;
    • Gisslinger, Bettina
    Publication type:
    Article
    8
    9

    Muscle and fat composition in patients with newly diagnosed multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00934-3
    By:
    • Abdallah, Nadine H.;
    • Nagayama, Hiroki;
    • Takahashi, Naoki;
    • Gonsalves, Wilson;
    • Fonder, Amie;
    • Dispenzieri, Angela;
    • Dingli, David;
    • Buadi, Francis K.;
    • Lacy, Martha Q.;
    • Hobbs, Miriam;
    • Gertz, Morie A.;
    • Binder, Moritz;
    • Kapoor, Prashant;
    • Warsame, Rahma;
    • Hayman, Suzanne R.;
    • Kourelis, Taxiarchis;
    • Hwa, Yi L.;
    • Lin, Yi;
    • Kyle, Robert A.;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    10

    Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
    By:
    • Charalampous, Charalampos;
    • Goel, Utkarsh;
    • Kapoor, Prashant;
    • Binder, Moritz;
    • Buadi, Francis K.;
    • Cook, Joselle;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonder, Amie L.;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Hayman, Suzanne R.;
    • Hobbs, Miriam A.;
    • Hwa, Yi L.;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi;
    • Warsame, Rahma;
    • Kyle, Robert A.
    Publication type:
    Article
    11

    Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00944-1
    By:
    • Pérez-Escurza, Oihane;
    • Flores-Montero, Juan;
    • Óskarsson, Jón Þórir;
    • Sanoja-Flores, Luzalba;
    • del Pozo, Julio;
    • Lecrevisse, Quentin;
    • Martín, Silvia;
    • Reed, Elín Ruth;
    • Hákonardóttir, Guðlaug Katrín;
    • Harding, Stephen;
    • Þorsteinsdóttir, Sigrún;
    • Rögnvaldsson, Sæmundur;
    • Love, Thorvardur Jon;
    • Durie, Brian;
    • Kristinsson, Sigurður Yngvi;
    • Orfao, Alberto
    Publication type:
    Article
    12
    13
    14

    Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00946-z
    By:
    • Visram, A.;
    • De La Torre, A.;
    • White, D.;
    • Su, J.;
    • Masih-Khan, E.;
    • Chu, M.;
    • Jimenez-Zepeda, V.;
    • McCurdy, A.;
    • LeBlanc, R.;
    • Song, K.;
    • Mian, H.;
    • Louzada, M.;
    • Sebag, M.;
    • Bergstrom, D.;
    • Stakiw, J.;
    • Reiman, A.;
    • Kotb, R.;
    • Aslam, M.;
    • Venner, C.;
    • Kaedbey, R.
    Publication type:
    Article
    15

    Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00949-w
    By:
    • Huang, Dan-Ping;
    • Yang, Liang-Chun;
    • Chen, Yi-Qiao;
    • Wan, Wu-Qing;
    • Zhou, Dun-Hua;
    • Mai, Hui-Rong;
    • Li, Wan-Li;
    • Yang, Li-Hua;
    • Lan, He-Kui;
    • Chen, Hui-Qin;
    • Guo, Bi-Yun;
    • Zhen, Zi-Jun;
    • Liu, Ri-Yang;
    • Chen, Guo-Hua;
    • Feng, Xiao-Qin;
    • Liang, Cong;
    • Wang, Li-Na;
    • Li, Yu;
    • Luo, Jie-Si;
    • Fan, Zhong
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
    By:
    • Bock, Allison M.;
    • Gile, Jennifer J.;
    • Larson, Melissa C.;
    • Poonsombudlert, Kittika;
    • Tawfiq, Reema K.;
    • Maliske, Seth;
    • Maurer, Matthew J.;
    • Kabat, Brian F.;
    • Paludo, Jonas;
    • Inwards, David J.;
    • Ayyappan, Sabarish;
    • Link, Brian K.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Cerhan, James R.;
    • Farooq, Umar;
    • Wang, Yucai
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00936-1
    By:
    • Vieri, Margherita;
    • Tharmapalan, Vithurithra;
    • Kalmer, Milena;
    • Baumeister, Julian;
    • Nikolić, Miloš;
    • Schnitker, Matthis;
    • Kirschner, Martin;
    • Flosdorf, Niclas;
    • de Toledo, Marcelo A. S.;
    • Zenke, Martin;
    • Koschmieder, Steffen;
    • Brümmendorf, Tim H.;
    • Beier, Fabian;
    • Wagner, Wolfgang
    Publication type:
    Article
    31
    32
    33
    34

    Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00905-8
    By:
    • Côté, Julie;
    • LeBlanc, Richard;
    • Mian, Hira;
    • Chu, Michael P.;
    • McCurdy, Arleigh;
    • Masih-Khan, Esther;
    • Su, Jiandong;
    • Jimenez-Zepeda, Victor H.;
    • Song, Kevin;
    • Louzada, Martha;
    • White, Darrell;
    • Sebag, Michael;
    • Reiman, Anthony;
    • Stakiw, Julie;
    • Kotb, Rami;
    • Bergstrom, Debra;
    • Aslam, Muhammad;
    • Kaedbey, Rayan;
    • Venner, Christopher P.;
    • Gul, Engin
    Publication type:
    Article
    35
    36
    37

    Reducing the risks of nuclear war—the role of health professionals.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00925-4
    By:
    • Abbasi, Kamran;
    • Ali, Parveen;
    • Barbour, Virginia;
    • Bibbins-Domingo, Kirsten;
    • Rikkert, Marcel G. M. Olde;
    • Horton, Richard;
    • Mash, Robert;
    • Monteiro, Carlos;
    • Naumova, Elena N.;
    • Rubin, Eric J.;
    • Sahni, Peush;
    • Tumwine, James;
    • Yonga, Paul;
    • Zielinski, Chris;
    • Mitra, Arun;
    • Ruff, Tilman;
    • Haines, Andy;
    • Helfand, Ira
    Publication type:
    Article
    38
    39
    40
    41
    42

    Zanubrutinib: past, present, and future.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
    By:
    • Tam, Constantine S.;
    • Muñoz, Javier L.;
    • Seymour, John F.;
    • Opat, Stephen
    Publication type:
    Article
    43

    Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    2023
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Correction Notice
    44

    Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00906-7
    By:
    • Sandecka, Viera;
    • Popkova, Tereza;
    • Stork, Martin;
    • Maisnar, Vladimir;
    • Minarik, Jiri;
    • Jungova, Alexandra;
    • Pavlicek, Petr;
    • Stejskal, Lukas;
    • Pospisilova, Lenka;
    • Heindorfer, Adriana;
    • Obernauerova, Jarmila;
    • Gregora, Evzen;
    • Sykora, Michal;
    • Ullrychova, Jana;
    • Wrobel, Marek;
    • Kessler, Petr;
    • Jelinek, Tomas;
    • Kunovszki, Peter;
    • Bathija, Sacheeta;
    • Gros, Blanca
    Publication type:
    Article
    45

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    46

    Late effects in survivors of infant acute lymphoblastic leukaemia—a study of the Australian and New Zealand Children's Haematology/Oncology Group.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00924-5
    By:
    • Mironova, Denitza;
    • Saraswati, Chitra M.;
    • Downie, Peter;
    • Lai, Chow Yee;
    • Cook, Eleanor;
    • Carruthers, Vickyanne;
    • Moukhaiber, Perla;
    • Molloy, Fiona;
    • Serov, Joshua;
    • McKinnon, Elizabeth;
    • Alvaro, Frank;
    • Osborn, Michael;
    • Revesz, Tamas;
    • Prestidge, Tim;
    • Cross, Siobhan;
    • Bateman, Caroline M.;
    • Moore, Andrew S.;
    • Khaw, Seong Lin;
    • Mateos, Marion K.;
    • Kotecha, Rishi S.
    Publication type:
    Article
    47
    48
    49

    Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00915-6
    By:
    • Hammond, Danielle;
    • Loghavi, Sanam;
    • Wang, Sa A.;
    • Konopleva, Marina Y.;
    • Kadia, Tapan M.;
    • Daver, Naval G.;
    • Ohanian, Maro;
    • Issa, Ghayas C.;
    • Alvarado, Yesid;
    • Short, Nicholas J.;
    • Sasaki, Koji;
    • Pemmaraju, Naveen;
    • Montalban-Bravo, Guillermo;
    • Lachowiez, Curtis A.;
    • Maiti, Abhishek;
    • Garcia-Manero, Guillermo;
    • Jabbour, Elias J.;
    • Borthakur, Gautam;
    • Ravandi, Farhad;
    • Takahashi, Koichi
    Publication type:
    Article
    50